Secondary hyperparathyroidism: Pathophysiology, histopathology, and medical and surgical management

Surgery Today

Volumn 27, Issue 9, 1997, Pages 787-792

  Tominaga, Yoshihiro ^a   Johansson, Hans ^b   Johansson, Henry ^b   Takagi, Hiroshi ^c  

^a NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic renal failure; Parathyroidectomy; Secondary hyperparathyroidism

Indexed keywords

CALCITRIOL; CALCIUM ANTAGONIST; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT;

HISTOPATHOLOGY; HUMAN; HYPERPHOSPHATEMIA; HYPOCALCEMIA; KIDNEY FAILURE; PARATHYROIDECTOMY; REVIEW; SECONDARY HYPERPARATHYROIDISM;

HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; PARATHYROID GLANDS; PARATHYROIDECTOMY;

EID: 0030881706     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02385267     Document Type: Review

References (47)

1. Albright F, Baird PC, Cope O, Bloomberg E (1934) Studies on the physiology of parathyroid glands. IV. Renal complications of hyperparathyroidism. Am J Med Sci 187:49-65
2. Rothmund M (1986) Surgical treatment of secondary hyperparathyroidism: Indication, operative management and result. Prog Surg 18:186-205
3. Llach F (1990) Parathyroidectomy in chronic renal failure: Indications, surgical approach and use of calcitriol. Kidney Int 38:S62-S68
4. Ritz E, Matthias S, Seidel A, Reichel H, Szabo A, Horl WH (1992) Disturbed calcium metabolism in renal failure - Pathogenesis and therapeutic strategies. Kidney Int 42 (Suppl 38):S37-S42
5. Naveh-Many T, Rahamimov R, Silver J (1995) Parathyroid cell proliferation in normal and chronic renal failure rats. J Clin Invest 96:1786-1793
6. Yi H, Fukagawa M, Yamamoto H, Kumagai M, Watanabe T, Kurokawa K (1995) Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus retention in early chronic renal failure in rats: Possible direct role of phosphorous. Nephron 70:242-248
7. 3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells. Calcif Tiss Int 43:213-218
8. Shvil Y, Naveh-Many T, Barach P, Silver P (1990) Regulation of parathyroid cell gene expression in experimental uremia. J Am Soc Nephrol 1:99-104
9. 3 inhibits parathyroid cell proliferation in experimantal uremia. Kidney Int 35:1049-1056
10. Schaefer F, Mehls O, Ritz E (1992) New insights into endocrine disturbance of chronic renal failure. Miner Electrolyte Metab 18:169-173
11. Eisman JA (1994) Vitamin D and cancer: New insight into vitamin D physiology and potential for cancer therapy. In: Heersche JNH, Kanis JA (eds) Bone and mineral research. Elsevier, Amsterdam, vol 8, pp 45-76
12. 2D in the genesis of secondary hyperparathyroidism of early renal failure and its use in the prevention of this abnormality. Metabolism 39:13-17
13. 3 levels in early renal failure? Clin Nephrol 36:274-280
14. Dusso AS, Finch J, Brown A, Ritter C, Delmez J, Schreiner G, Slatopolsky E (1991) Extrarenal production of calcitriol in normal and uremic humans. J Clin Endocrinol Metab 72:157-164
15. 3 in the parathyroid glands of patients with renal failure. N Engl J Med 316:1573-1577
16. 3 in the parathyroid in vivo. J Clin Invest 86:1968-1975
17. Reichel H, Szato A, Uhl J (1992) Intermittent venous continuous administration of calcitriol: Comparison of efficacy. (Abstract) Nephrol Dial Transplant 7:762
18. Delmez JA, Tindire C, Grooms P, Dusso A, Windus DW, Slatopolsky E (1989) Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium. J Clin Invest 83:1349-1355
19. Tominaga Y, Sato K, Tanaka Y, Numano M, Uchida K, Takagi H (1995) Histopathology and pathophysiology of secondary hyperparathyroidism due to chronic renal failure. Clin Nephrol 144: S42-S47
20. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92:1436-1443
21. Johansson H, Rastad J, Bjerneroth G, Gylfe E, Åkerström G (1989) Microfluorometric measurements of cytoplasmic calcium in chief and oxyphil parathyroid cells of adenomatous and hyperplastic glands and of normal-sized glands associated with adenomas. Surgery 106:517-524
22. Tominaga Y, Numano M, Uchida K, Katayama A, Haba T, Asano H, Sato K, Tanaka Y, Takagi H (1994) Parathyroidectomy for patients with renal hyperparathyroidism refractory to calcitriol pulse therapy. J Bone Miner Met 12 (Suppl 1):S99-S104.
23. Naven-Many, Rahamimov R, Silver J (1995) Parathyroid cell proliferation in normal and chronic renal failure rats. J Clin Invest 96:1786-1793
24. Malmaeus J, Grimelius L, Johansson H, Åkerström G, Ljunghall S (1984) Parathyroid pathology in hyperparathyroidism secondary to chronic renal failure. Scand J Urol Nephrol 18:157-166
25. Nygren P, Larsson R, Gylfe E, Lindh E, Ljunghall S, Rastad J, Åkerström G (1987) Development of abnormal parathyroid cell function during monolayer culture and its relation to cellular hypertrophy and proliferation. Acta Pathol. Microbiol Immunol Scand (A) 95:207-214
26. Nygren P, Larsson R, Johansson H (1988) Inhibition of cell gorwth retains differentiated function of bovine parathyroid cells in monolayer cutlure. Bone Miner 4:123-132
27. Lloyd HM, Parfitt AM, Jacobi JM, Willgoss PW, Craswell PW, Petrie JJB, Boyle PD (1989) The parathyroid glands in chronic renal failure: A study of their growth and other properties made on the basis of findings in patients with hypercalcemia. J Lab Clin Med 114:358-367
28. Sakaguchi K, Santora A, Zimering M, Curcio F, Auerbach GD, Brandi M-L (1987) Functional epithelial cell line cloned from rat parathyroid glands. Proc Natl Acad Sci USA 84:3269-3273
29. Arnold A, Brown MF, Urena P, Gaz RD, Sarfati E, Drüeke T (1995) Monoclonality of parathyroid tumors in chronic renal failure and primary parathyroid hyperplasia. J Clin Invest 95:2047-2053
30. Tominaga Y, Kohara S, Namii Y, Nagasaka T, Haba T, Uchida K, Numano M, Tanaka Y, Takagi H (1996) Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism. World J Surg 20:744-752
31. Falchetti A, Bale AE, Amorosi A, Bordi C, Cicchi P, Brandini S, Marx SJ, Brandi ML (1993) Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. J Clin Endocrinol Metab 76:139-144
32. Tominaga Y, Takagi H (1996) Molecular geneticus of hyperparathyroid disease. Curr Opinion Nephrol Hypertens 5:336-541
33. Akizawa T, Fukagawa M, Koshikawa S, Kurokawa K (1993) Recent progress in management of secondary hyperparathyroidism of chronic renal failure. Curr Opinion Nephrol Hypertens 2:558-565
34. Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ (1984) Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferiol in uremic patients. J Clin Invest 74:2136-2143
35. 3 pulse therapy in hemodialysis patients with severe secondary hvperparathyroidism. Nephron 57:23-28
36. Andress DL, Norris KC, Coburn JW, Slatopolsky EA, Sherrard DJ (1989) Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 321:274-279
37. Ljunghall S, Althoff P, Fellstrom B, Marjanovic B, Nisell J, Weiss L, Wide L (1990) Effects on serum parathyroid hormone of intravenous treatment with alphacalcidol in patients on chronic hemodialysis. Nephron 55:380-385
38. Garrick R, Kumar U, Fallon M (1991) The efficacy of intravenous (IV) and oral (PO) calcitriol (C) in the treatment of renal osteodystrophy. (Abstrace) J Am Soc Nephrol 2:610
39. Fukagawa M, Kitaoka M, Yi H, Fukuda N, Ogata E, Kurokawa K (1994) Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calictriol pulse therapy in chronic dialysis patient. Nephron 68:221-228
40. 3 derivatives in the treatment of renal bone disease: Justification and optimal modalities of administration. Nephron 71:254-283
41. Tominaga Y, Sato K, Numano M, Tanaka Y, Takagi H (1994) Surgical treatment of renal hyperparathyroidism. Asian J Surg 17:121-126
42. Tominaga Y, Tanaka Y, Sato K, Numano M, Uchida K, Takagi H (1991) Surgical treatment of secondary hyperparathyroidism. J Bone Min Met 3:294-300
43. Rastad J, Åkerström G. (1994) Secondary hyperparathyroidism. In: Åkerström G, Juhlin C, Rastad J (eds) Medical intelligence unit: Current controversy in parathyroid operation and reoperation. RG Landes, Austin pp 167-200
44. Takagi H, Tominaga Y, Uchida K, Yamada Y, Kawai M, Kano T, Morimoto T (1984) Subtotal versus total parathyroidectomy with forearm autograft for secondary hyperparthyroidism in chronic renal failure. Ann Surg 200:18-23
45. Takagi H, Tominaga Y, Uchida K, Yamada N, Morimoto T, Yasue M (1983) Image diagnosis of parathyroid glands in chronic renal failure. Ann Surg 198:74-79
46. Tominaga Y, Tanaka Y, Sato K, Numano M, Uchida K, Falkmer U, Grimelius L, Johansson H, Takagi H (1942) Recurrent renal hyperparathyroidism ane DNA analysis of autografted parathyroid tissue. World J Surg 16:595-603
47. Hellman P, Åkerström G, Ljunghall S, Rastad J (1989) Surgical findings and results of subtotal and total parathyroidectomy in hypercalcemic patients with uremic hyperparathyroidism. Acta Chir Scand 155:573-582